BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18646607)

  • 1. [Detection of minimal residual disease in leukemia using flow cytometry].
    Muroi K
    Rinsho Ketsueki; 2008 Jun; 49(6):397-407. PubMed ID: 18646607
    [No Abstract]   [Full Text] [Related]  

  • 2. A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry.
    Capolunghi F; Capponi C; De Stefani B; Luciani M; Locatelli F; Muraca M; Carsetti R
    Am J Hematol; 2014 Mar; 89(3):343-4. PubMed ID: 24265183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring minimal residual disease in pediatric hematologic malignancies.
    Campana D
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):876-7, 915. PubMed ID: 18185484
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimal residual disease detection by flow cytometry.
    Ludwig WD
    Lab Hematol; 2004; 10(3):169. PubMed ID: 15529435
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
    Digiuseppe JA
    Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection and significance of minimal residual disease in acute and chronic leukemia.
    Chung NG; Buxhofer-Ausch V; Radich JP
    Tissue Antigens; 2006 Nov; 68(5):371-85. PubMed ID: 17092250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
    Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
    Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
    Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
    Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of flow cytometry to detect minimal residual disease in acute leukemia.
    Campana D; Coustan-Smith E
    Eur J Histochem; 1996; 40 Suppl 1():39-42. PubMed ID: 8839698
    [No Abstract]   [Full Text] [Related]  

  • 12. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
    Muzzafar T; Medeiros LJ; Wang SA; Brahmandam A; Thomas DA; Jorgensen JL
    Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia.
    Krampera M; Perbellini O; Maggioni A; Scognamiglio F; Todeschini G; Pizzolo G
    Haematologica; 2001 Mar; 86(3):322-3. PubMed ID: 11255283
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
    Mlcáková A; Babusíková O
    Neoplasma; 2003; 50(6):416-21. PubMed ID: 14689062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
    Krampera M; Perbellini O; Vincenzi C; Zampieri F; Pasini A; Scupoli MT; Guarini A; De Propris MS; Coustan-Smith E; Campana D; Foà R; Pizzolo G
    Haematologica; 2006 Aug; 91(8):1109-12. PubMed ID: 16885052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A; Gillis D; Hissaria P; Lewis I
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.
    Lioznov M; Badbaran A; Fehse B; Bacher U; Zander AR; Kröger NM
    Bone Marrow Transplant; 2008 May; 41(10):913-6. PubMed ID: 18264143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry].
    Tousková M; Maisnar V; Krejsek J; Kopecký O
    Vnitr Lek; 1999 Dec; 45(12):708-12. PubMed ID: 10951845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric monitoring of residual disease in acute leukemia.
    Wood BL
    Methods Mol Biol; 2013; 999():123-36. PubMed ID: 23666694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.